Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Apitope Technology
Biotech
Apitope preps Graves’ disease drug for phase 2
Apitope hopes to end a 60-year drought in new therapies for thyroid disorder Graves’ disease, which affects 10 million people in the U.S. and Europe.
Phil Taylor
Apr 16, 2018 10:40am
After Merck KGaA rejection, Apitope advances MS drug
Feb 22, 2017 7:42am
Merck KGaA returns PhII multiple sclerosis drug to Apitope
Oct 17, 2016 8:47am
